Abstract
The objective of this study was to assess the associations of asthma control with hypertension, cardiovascular disease, and mortality in obese individuals. We used data from the National Health and Nutrition Examination Survey (NHANES), 2001–2018. Weighted logistic regression analyses and Cox proportional hazard models were performed to evaluate the influence of asthma control on hypertension, cardiovascular disease, and mortality. A total of 2744 obese participants were included. Of them, 937 participants had poorly controlled asthma, 873 had well-controlled asthma, and 934 did not have asthma. We found that poorly controlled asthma was associated with an increased risk of angina pectoris, congestive heart failure (CHF), stroke, and all-cause mortality in obese participants, while well-controlled asthma was associated with an increased risk of CHF and all-cause mortality. Compared with patients with poorly controlled asthma, patients with well-controlled asthma were at low risk of angina pectoris (OR [odds ratio], 0.49; 95% CI [confidence interval], 0.29–0.81), heart attack (OR, 0.54; 95% CI 0.34–0.87), CHF (OR, 0.62; 95% CI 0.39–0.99), and stroke (OR, 0.45; 95% CI 0.27–0.73). The present study suggested that obese individuals with poorly controlled asthma were associated with increased risks of angina pectoris, CHF, stroke, and all-cause mortality. Well-controlled asthma had fewer negative health effects than poorly controlled asthma in obese individuals.
Similar content being viewed by others
Availability of data and materials
Data are available on the website: https://www.cdc.gov/nchs/nhanes/index.htm.
Abbreviations
- NHANES:
-
National Health and Nutrition Examination Survey
- CDC:
-
Centers for Disease Control and Prevention
- BMI:
-
Body mass index
- GED:
-
General educational development
- CHD:
-
Coronary heart disease
- CHF:
-
Congestive heart failure
- MEC:
-
Mobile Examination Center
- CVD:
-
Cardiovascular disease
- SD:
-
Standard deviation
- ICD:
-
International classification of disease
- ACQ:
-
Asthma control questionnaire
- OSA:
-
Obstructive sleep apnea
- ICS:
-
Inhaled corticosteroids
- OR:
-
Odds ratios
- HR:
-
Hazard ratio
- CI:
-
Confidence interval
References
Blüher M (2019) Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 15(5):288–298
World Health O (2022) WHO European regional obesity report 2022. World Health Organization Regional Office for Europe, Geneva
Cercato C, Fonseca FA (2019) Cardiovascular risk and obesity. Diabetol Metab Syndr 11(1):1–15
Jahangir E, De Schutter A, Lavie CJ (2014) The relationship between obesity and coronary artery disease. Transl Res 164(4):336–344
Nicklas BJ, Cesari M, Penninx BWJH, Kritchevsky SB, Ding J, Newman A et al (2006) Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc 54(3):413–420
Goel V, Han H-C, Ha F, Fendel K, Farouque O, Lim H (2020) Obesity and sudden cardiac death in the young: a nationwide retrospective study. J Am Coll Cardiol 75(11_Supplement_1):1912
Carratù P, Di Ciaula A, Dragonieri S, Ranieri T, Matteo Ciccone M, Portincasa P et al (2021) Relationships between obstructive sleep apnea syndrome and cardiovascular risk in a naïve population of southern Italy. Int J Clin Pract 75(12):e14952. https://doi.org/10.1111/ijcp.14952. (Epub 2021/10/06. PubMed PMID: 34610197; PubMed Central PMCID: PMCPMC9285080)
Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ et al (2021) Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation 143(21):e984–e1010
Christiansen SC, Zuraw BL (2019) Treatment of hypertension in patients with asthma. N Engl J Med 381(11):1046–1057
Wee JH, Park MW, Min C, Byun SH, Park B, Choi HG (2021) Association between asthma and cardiovascular disease. Eur J Clin Invest 51(3):e13396
Bellia V, Pedone C, Catalano F, Zito A, Davià E, Palange S et al (2007) Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest 132(4):1175–1182
Barros R, Moreira P, Padrão P, Teixeira VH, Carvalho P, Delgado L et al (2017) Obesity increases the prevalence and the incidence of asthma and worsens asthma severity. Clin Nutr 36(4):1068–1074
Ahmadizar F, Vijverberg SJ, Arets HG, de Boer A, Lang JE, Kattan M et al (2016) Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis. Eur Respir J 48(4):1063–1073. https://doi.org/10.1183/13993003.00766-2016. (Epub 2016/09/03. PubMed PMID: 27587561)
Centers for disease control and prevention (CDC) (2017) About the national health and nutrition examination survey. https://www.cdc.gov/nchs/nhanes/index.htm. Accessed 26 Aug 2023
National center for health statistics division of analysis and epidemiology. Continuous NHANES public-use linked mortality files, 2019. Hyattsville, Maryland. https://www.cdc.gov/nchs/data-linkage/mortality-public.htm. Accessed 26 Aug 2023
Miethe S, Karsonova A, Karaulov A, Renz H (2020) Obesity and asthma. J Allergy Clin Immunol 146(4):685–693
Everaere L, Ait Yahia S, Bouté M, Audousset C, Chenivesse C, Tsicopoulos A (2018) Innate lymphoid cells at the interface between obesity and asthma. Immunology 153(1):21–30
Martinez FD, Guerra S (2018) Early origins of asthma. Role of microbial dysbiosis and metabolic dysfunction. Am J Respir Crit Care Med 197(5):573–579
Farah CS, Salome CM (2012) Asthma and obesity: a known association but unknown mechanism. Respirology 17(3):412–421
Appleton SL, Ruffin RE, Wilson DH, Taylor AW, Adams RJ (2008) Asthma is associated with cardiovascular disease in a representative population sample. Obes Res Clin Pract 2(2):91–99
Scott HA, Wood LG, Gibson PG (2017) Role of obesity in asthma: mechanisms and management strategies. Curr Allergy Asthma Rep 17:1–10
Juel CT-B, Ulrik CS (2013) Obesity and asthma: impact on severity, asthma control, and response to therapy. Respir Care 58(5):867–873
Milara J, Morell A, Roger I, Montero P, Cortijo J (2023) Mechanisms underlying corticosteroid resistance in patients with asthma: a review of current knowledge. Exp Rev Respir Med 17(8):701–715. https://doi.org/10.1080/17476348.2023.2255124. (Epub 2023/09/02. PubMed PMID: 37658478)
Gibson PG, Reddel H, McDonald VM, Marks G, Jenkins C, Gillman A et al (2016) Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Intern Med J 46(9):1054–1062
Jehan S, Myers AK, Zizi F, Pandi-Perumal SR, Jean-Louis G, McFarlane SI (2018) Obesity, obstructive sleep apnea and type 2 diabetes mellitus: epidemiology and pathophysiologic insights. Sleep Med Disord: Int J 2(3):52
Maccioni L, Weber S, Elgizouli M, Stoehlker A-S, Geist I, Peter H-H et al (2018) Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study. BMC Public Health 18(1):1–13
Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143(3):199–211
Rogers L (2016) Role of sleep apnea and gastroesophageal reflux in severe asthma. Immunol Allergy Clin 36(3):461–471
Busse WW, Lemanske RF, Gern JE (2010) Role of viral respiratory infections in asthma and asthma exacerbations. The Lancet 376(9743):826–834
Dias-Júnior SA, Reis M, de Carvalho-Pinto RM, Stelmach R, Halpern A, Cukier A (2014) Effects of weight loss on asthma control in obese patients with severe asthma. Eur Respir J 43(5):1368–1377
Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D et al (2015) European guidelines for obesity management in adults. Obes Facts 8(6):402–424
Acknowledgements
Not applicable
Funding
None.
Author information
Authors and Affiliations
Contributions
PL contributed to study concept and design, data analysis, drafting the article, and critical revision. YZ contributed to data analysis, and drafting the article. ZL and YS contributed to study design, critical revision, final approval and submitted the report for publication. All authors listed have approved the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The protocols of NHANES were approved by the institutional review board of the National Center for Health Statistics, CDC. Written informed consent was obtained from each participant before participation in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lin, P., Zhao, Y., Shi, Y. et al. Associations of asthma control with hypertension, cardiovascular disease, and mortality in obese individuals. Intern Emerg Med (2024). https://doi.org/10.1007/s11739-024-03554-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11739-024-03554-2